CLINICAL_TRIALS
withdrawal
· 2018-07-17
Clinical Trial Update: The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study) [NA]
Summary
The LTX-Stent Study investigating the influence of cirrhosis of the liver on coronary restenosis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: RWTH Aachen University | Conditions: Re-stenosis, Cirrhosis of the Liver | NA | Status: WITHDRAWN